Differential Bio is enabling the next wave of cost-competitive bioproducts through lab automation and AI.
Differential Bio has raised $2.1M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.
Differential Bio's investors include Ananda Impact Ventures, Carbon13, ReGen Ventures, better ventures, Climate Capital.
Differential Bio is headquartered in Munich, Germany.
Differential Bio is enabling the next wave of cost-competitive bioproducts through lab automation and AI.
Differential Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Differential Bio — Funding & Investors." VCBacked, December 1, 2024, https://www.vcbacked.co/company/differential-bio. Accessed November 15, 2026.
VCBacked. (2024). Differential Bio — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/differential-bio
{{cite web |title=Differential Bio — Funding & Investors |url=https://www.vcbacked.co/company/differential-bio |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Differential Bio? Request a listing update